Menu

Report Library

All Reports

JP Morgan 2018 - Day 2

January 09, 2018

The 36th annual JP Morgan Healthcare Conference is being held in San Francisco, CA from January 8-11, 2018. A list of events and catalysts that were announced or updated at the conference today is included in this report.

Highlights from today’s company presentations are included for:

Large Cap
  • Amgen (AMGN)
  • Bristol-Myers Squibb (BMY)
  • Roche (RHHBY)
  • Astellas (ALPMY)
Mid Cap
  • Amicus (FOLD)
  • Nektar (NKTR)
  • Alkermes (ALKS)
  • SAGE (SAGE)
  • Apellis (APLS)
  • Bluebird (BLUE)
  • Acadia (ACAD)
  • Halozyme (HALO)
  • Clovis Oncology (CLVS)
  • Juno (JUNO)
  • Horizon Pharma (HZNP)
Small Cap
  • Amag (AMAG)
  • Lexicon (LXRX)
  • Myokardia (MYOK)
Micro Cap
  • Axovant (AXON)

For the full report, please download the PDF version at the top of this page.

For our disclosures, please read the Biomedtracker Research Standards.
Disease Group Covered: Allergy
Autoimmune/immunology
Cardiovascular
Dermatology
Endocrine
ENT/Dental
Gastroenterology (Non Inflammatory Bowel Disease)
Hematology
Infectious Disease
Metabolic
Neurology
Not Specified
Obstetrics/Gynecology
Oncology
Ophthalmology
Orthopedics
Psychiatry
Renal
Respiratory
Rheumatology (Non Autoimmune)
Urology

 Additional Resources: